Sinocelltech Group Stock Current Valuation
| 688520 Stock | 39.00 0.62 1.62% |
Valuation analysis of Sinocelltech Group helps investors to measure Sinocelltech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Other Non Cash Items is expected to grow to about 133.6 M, whereas Cash is forecasted to decline to about 278.7 M. Fundamental drivers impacting Sinocelltech's valuation include:
Enterprise Value 19.4 B | Enterprise Value Ebitda 228.1745 | Price Sales 7.1033 | Enterprise Value Revenue 7.938 |
Overvalued
Today
Please note that Sinocelltech's price fluctuation is not too volatile at this time. Calculation of the real value of Sinocelltech Group is based on 3 months time horizon. Increasing Sinocelltech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Sinocelltech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sinocelltech Stock. However, Sinocelltech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.0 | Real 33.12 | Hype 40.12 | Naive 37.51 |
The real value of Sinocelltech Stock, also known as its intrinsic value, is the underlying worth of Sinocelltech Group Company, which is reflected in its stock price. It is based on Sinocelltech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sinocelltech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sinocelltech Group helps investors to forecast how Sinocelltech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sinocelltech more accurately as focusing exclusively on Sinocelltech's fundamentals will not take into account other important factors: Sinocelltech Group Company Current Valuation Analysis
Sinocelltech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Sinocelltech Current Valuation | 19.41 B |
Most of Sinocelltech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sinocelltech Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Sinocelltech Group has a Current Valuation of 19.41 B. This is 35.13% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is 16.75% lower than that of the firm.
Sinocelltech Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sinocelltech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sinocelltech could also be used in its relative valuation, which is a method of valuing Sinocelltech by comparing valuation metrics of similar companies.Sinocelltech is currently under evaluation in current valuation category among its peers.
Sinocelltech Fundamentals
| Return On Equity | -38.64 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 19.41 B | ||||
| Shares Outstanding | 445.34 M | ||||
| Shares Owned By Insiders | 77.23 % | ||||
| Shares Owned By Institutions | 5.45 % | ||||
| Price To Sales | 7.10 X | ||||
| Revenue | 1.89 B | ||||
| Gross Profit | 1.02 B | ||||
| EBITDA | 613.46 M | ||||
| Net Income | (396.02 M) | ||||
| Total Debt | 1.65 B | ||||
| Book Value Per Share | (0.96) X | ||||
| Cash Flow From Operations | (383.37 M) | ||||
| Earnings Per Share | (0.06) X | ||||
| Target Price | 65.0 | ||||
| Number Of Employees | 2.31 K | ||||
| Beta | 0.63 | ||||
| Market Capitalization | 17.37 B | ||||
| Total Asset | 2.72 B | ||||
| Retained Earnings | (3.93 B) | ||||
| Working Capital | (966.13 M) | ||||
| Net Asset | 2.72 B |
About Sinocelltech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sinocelltech Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sinocelltech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sinocelltech Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sinocelltech Stock
Sinocelltech financial ratios help investors to determine whether Sinocelltech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sinocelltech with respect to the benefits of owning Sinocelltech security.